Homeopathic specialities as a substitute for benzodiazepines:: a double-blind vs. placebo study

被引:0
|
作者
Cialdella, P
Boissel, JP
Belon, P
机构
[1] Fac RTH Laennec, Serv Pharmacol Clin, F-69376 Lyon 08, France
[2] Lab BOIRON, F-69110 St Foy Les Lyon, France
来源
THERAPIE | 2001年 / 56卷 / 04期
关键词
controlled clinical trial; homeopathy; benzodiazepines; substitutive treatment; placebo;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to compare the efficacy of homeopathic drugs Homeogene 46 (R) and Sedatif PC (R) with a placebo as substitute for benzodiazepines in patients treated for at least 3 months with low doses (less than 10 mg/d of diazepam equivalents). A double-blind randomized trial was carried out in general practice. The treatment lasted one month. Several rating scales were used. The main outcome was success/failure defined according to the doctor's clinical judgement and interruption of treatment. A total of 61 patients were randomized, and 19 interrupted their treatment. Comparability between the groups was good. No statistically significant difference between homeopathic drugs and placebo was observed for the main outcome or for the secondary outcomes. The lack of statistical power due to accrual difficulties limits the conclusions of this trial which did not confirm the efficacy of homeopathic drugs in this indication.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 50 条
  • [1] Risperidone vs. quetiapine in inpatients with schizophrenia: a double-blind placebo-controlled study
    Greenspan, A
    Kosik-Gonzalez, C
    Moreau-Matlet, V
    Bossie, CA
    Rupnow, MFT
    Zhu, Y
    Gharabawi, GM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S503 - S504
  • [2] Melatonin vs. midazolam premedication in children: a double-blind, placebo-controlled study
    Samarkandi, A
    Naguib, M
    Riad, W
    Thalaj, A
    Alotibi, W
    Aldammas, E
    Albassam, A
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2005, 22 (03) : 189 - 196
  • [3] Re: Clomipramine vs. haloperidol in the treatment of autistic disorder: A double-blind, placebo, crossover study
    King, R
    Fay, G
    Wheildon, H
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 525 - 526
  • [4] Homeopathic vs conventional treatment of vertigo -: A randomized double-blind controlled clinical study
    Weiser, M
    Strösser, W
    Klein, P
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1998, 124 (08) : 879 - 885
  • [5] Re: Clomipramine vs. haloperidol in the treatment of autistic disorder: A double-blind, placebo, crossover study - Reply
    Sloman, L
    Konstantareas, M
    Remington, G
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 526 - 526
  • [6] Double-blind crossover antidepressant study: Sertraline vs. imipramine
    Thase, ME
    Keller, MB
    Hirschfeld, RMA
    Schatzberg, A
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 312 - 312
  • [7] Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis
    Elewski, BE
    Scher, RK
    Aly, R
    Daniel, R
    Jones, HE
    Odom, RB
    Zaias, N
    Jacko, ML
    CUTIS, 1997, 59 (04): : 217 - 220
  • [8] A double-blind randomized clinical trial of gabapentin vs. placebo for treating alcohol dependence
    Brower, KJ
    Kim, HM
    Karam-Hage, MA
    Zucker, RA
    Greden, JF
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 84S - 85S
  • [9] Randomized Double-Blind Trial of Sublingual Atropine vs. Placebo for the Management of Death Rattle
    Heisler, Mark
    Hamilton, Gillian
    Abbott, Angela
    Chengalaram, Amy
    Koceja, Todd
    Gerkin, Richard
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 45 (01) : 14 - 22
  • [10] Efficacy of topical chamomile management vs. placebo in patients with oral lichen planus: a randomized double-blind study
    Lopez Jornet, P.
    Aznar-Cayuela, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (10) : 1783 - 1786